Status:
COMPLETED
Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)
Lead Sponsor:
Xiaojun Yang
Collaborating Sponsors:
M.D. Anderson Cancer Center
Sichuan Cancer Hospital and Research Institute
Conditions:
Patient-reported Outcomes
Eligibility:
All Genders
18+ years
Brief Summary
Investigators propose a multicenter prospective observational cohort study to develop and validate essential technical parameters for establishing the patient-reported outcome-based perioperative symp...
Eligibility Criteria
Inclusion
- Be pathologically or clinically diagnosed as primary lung cancer before surgery;
- Plan to undergo a surgical procedure.
Exclusion
- Aged younger than 18;
- Diagnosis of cognitive impairment or unable to understand the study requirements.
Key Trial Info
Start Date :
November 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
512 Patients enrolled
Trial Details
Trial ID
NCT03341377
Start Date
November 21 2017
End Date
January 1 2020
Last Update
October 28 2020
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Sichuan Cancer Hospital and Research Institute
Chengdu, Sichuan, China, 610041
2
Chengdu Seventh People's Hospital
Chengdu, Sichuan, China
3
Chengdu Third People's Hospital
Chengdu, Sichuan, China
4
Dazhu County People's Hospital
Dazhou, Sichuan, China